One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to evaluate efficacy of AZD1981 in uncontrolled asthmatic patients on maintenance inhaled glucocorticosteroids.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca

Criteria

Inclusion Criteria:

• Six months history of asthma

• Daily use of inhaled glucocorticosteroids

• FEV1 40-85% of predicted normal

• Reversibility; increase in FEV1 more than 12% and 200 mL post-bronchodilator

Exclusion Criteria:

• Other clinically relevant disease or disorders

• History of smoking of more than 10 pack years

• Respiratory infection within 30 days